Assess the relationship between metformin use and prostate cancer risk in obese non-diabetic men.
Observational study design
Focus on obese men
Investigated metformin prescription rates
Analyzed prostate cancer incidence
Metformin use is linked to a lower risk of advanced prostate cancer.
Risk reduction is significant in early detection cases.
Findings support the potential repurposing of metformin for prostate cancer management.
Abstract
Metformin-use in obese men is associated with reduced PC risk, if detected early. Further research could inform the repurposing of metformin for PC control.
AI से पूछें
Like
Bookmark
Share
View Full Paper
Cite This Study
Nair-Shalliker et al. (Tue,) studied this question.